Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Dr. Malenka elected to National Academy of Sciences

Cure Alzheimer’s Fund Research Consortium Member recognized
for Work on Neuroscience and Neuropsychiatric Disorders

Boston— Praised for excellence in his innovative neuroscience research, Stanford University’s Dr. Robert Malenka, M.D., Ph.D. has been elected to the National Academy of Sciences. A member of Cure Alzheimer’s Fund Research Consortium, Malenka is the Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences, and director of the Nancy Friend Pritzker Laboratory at Stanford University.

Alan Arnette's final thoughts on Everest summit

As Alan Arnette prepares to depart Kathmandu after his climb to the top of the world's highest mountain, he blogs about how he and his team followed a traditional unique – signing a white board at the Rum Doodle restaurant in Kathmandu. Before signing it, his team had to show proof they summitted, a statement from the Ministry of Tourism with their names and expedition.

Alan Arnette reflects on reaching the top of Everest, mother's battle with Alzheimer's an inspiration

Crediting his mom's strength in her battle against Alzheimer's as an inspiration, Alan Arnette reflects on how he overcame the mental and physical demands of his climb up and down Mt. Everest.

In his latest blog Alan talks about how he found the strength to make it to the summit and says "the biggest difference was the inspiration and motivation that came from watching my mom struggle with Alzheimer’s. She did it with class, dignity and humor. She never let on how much it hurt. Her strength and courage kept me going every time I felt weak – physically or mentally."

Alan Arnette reaches top of Everest, 3rd summit reached on 7-Summits Climb for Alzheimer's

Alan Arnette was at the top of the world at sunrise today, Saturday 21, when he summitted Mt. Everest in Nepal. This is the 3rd mountain Alan has climbed in his 7-Summits Climb for Alzheimer's.

Listen to short radio dispatch Alan gave here. You can hear the emotion in his voice as he dedicates the climb to his mom and all those affected by the disease.

Alan Arnette radio dispatch at Everest base camp 4, peak in his sights in 7-Summits Climb for Alzheimer's

On his 7-Summits Climb for Alzheimer's, Alan Arnette has reached camp 4 in the South Col of Mt. Everest. He will be leaving for the summit very soon.

CAF applauds the Alzheimer's Foundation report calling for increased federal investment in aging research

As aging baby boomers are reaching the age of risk for Alzheimer's, the federal funding for research on aging diseases has been sorely inadequate, and it's time for the government to increased investment in research to better treat, prevent and cure diseases such as Alzheimer's, according to a new report released by the Alzheimer's Foundation of America (AFA).

“The model for funding academic research was insufficient, inefficient and ineffective” said Cure Alzheimer’s Fund co-founder and venture capitalist Henry McCance.

In Science/Business article CAF's Henry McCance discusses how he used his venture capital expertise to take on finding a cure for Alzheimer's after his wife was diagnosed with the disease 10 years ago.

McCance co-founded Cure Alzheimer's Fund  explaining “the model for funding academic research was insufficient, inefficient and ineffective.” McCance hopes this concept of venture research will catch on.

Read article here


NY Times online column highlights Cure Alzhemer's Fund's innovative approach to research

NY Times online columnist David Bornstein examines how the Cure Alzheimer's Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.

Read more

USA Today online features Cure Alzheimer's grant to Nobel Lauerate Paul Greengard

Cure Alzheimer's Fund's $100,000 grant to Rockefeller University's Dr. Paul Greengard was featured in USA Today online "Charity in the News: Week in Review." The Nobel Laureate will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.

Read more here


Support the Coast-to-Coast Solo Run to Cure Alzheimer’s

Photo of Glenn Caffery

On May 19, 2011, Glenn Caffery, age 49, set out from Seaside, Ore., to run 3,312 miles across the country to Westerly, R.I. He is running to honor his father—Dick Caffery—whom he lost to Alzheimer’s disease in 2002, and to raise money to help find a cure for this devastating illness. “Watching my father suffer made me feel so helpless,” says Caffery. “Since he’s passed away, I’ve felt like I needed to do something to help, and running across the country felt like something.”